United Therapeutics Corporation (UTHR) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 5.4% on average (either way), rising 6 times and falling 6. EPS beat estimates 6 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | 5.71 | 6.01 | -5.0% | 832.5M | 781.1M | -5.9% |
| Q2 FY2026 | 2026-08-05 | 7.27 | 6.86 | +6.0% | 783.3M | 804.6M | +2.7% |
| Q1 FY2026 | 2026-05-06 | 5.82 | 7.00 | -16.9% | 781.5M | 797.4M | -0.5% |
| Q4 FY2025 | 2026-02-25 | 7.70 | 7.13 | +8.0% | 790.2M | 813.1M | +6.4% |
| Q3 FY2025 | 2025-10-29 | 7.16 | 6.89 | +3.9% | 799.5M | 814.8M | +9.2% |
| Q2 FY2025 | 2025-07-30 | 6.41 | 7.29 | -12.1% | 798.6M | 801.9M | -7.7% |
| Q1 FY2025 | 2025-04-30 | 6.63 | 6.29 | +5.4% | 794.4M | 778.7M | -2.3% |
| Q4 FY2024 | 2025-02-26 | 6.19 | 6.40 | -3.3% | 735.9M | 734.7M | -9.5% |